Timothy Tyson

Timothy Tyson has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Syros Pharmaceuticals, Inc. and Tyme Technologies, Inc. We count 6 filings; the first trade dates from 16 September 2022 and the latest from 5 June 2024.

Purchases make up the whole of the open-market record (1 purchase). No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants.

Most recently, on 7 June 2024, the filings show a share grant in Syros Pharmaceuticals, Inc. The most recent open-market purchase was published on 3 October 2022, 1,476 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.